American Association for the Advancement of Science, Science Immunology, 51(5), 2020
DOI: 10.1126/sciimmunol.abd6197
Full text: Unavailable
Longitudinal analysis of the immune response in patients with COVID-19 identifies a myeloid signature associated with severe disease.